D, B., X, Y., Y, W., J, Y., F, Y., X, T., . . . P, L. (2026). Stimuli-responsive nanoplatforms for precision activation of the STING pathway in cancer immunotherapy. Frontiers in immunology, 17, 1714249. https://doi.org/10.3389/fimmu.2026.1714249
Chicago Style (17th ed.) CitationD, Bi, Yang X, Wang Y, Yong J, Yang F, Tan X, Li Y, Zheng D, and Li P. "Stimuli-responsive Nanoplatforms for Precision Activation of the STING Pathway in Cancer Immunotherapy." Frontiers in Immunology 17 (2026): 1714249. https://doi.org/10.3389/fimmu.2026.1714249.
MLA (9th ed.) CitationD, Bi, et al. "Stimuli-responsive Nanoplatforms for Precision Activation of the STING Pathway in Cancer Immunotherapy." Frontiers in Immunology, vol. 17, 2026, p. 1714249, https://doi.org/10.3389/fimmu.2026.1714249.